Physician profile
Y-Vu Van
NPI 1174056980
$2,235.25
in general payments reported to CMS, 2019-2025
11 companies · $1,651 in 2025
The $1,651 reported for 2025 was more than what 82% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $231 · 2024: $353 · 2025: $1,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,235.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $816.75 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kerecis Limited | $501.54 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Integra Lifesciences Corporation | $202.05 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $164.18 | 2025 | Novosorb Btm |
| Davol INC. | $161.44 | 2025 | Phasix Mesh |
| Axogen | $128.63 | 2025 | |
| Smith+Nephew, INC. | $91.74 | 2025 | Collagenase Santyl, Stravix Pl, Grafix Xc |
| Tactile Systems Technology INC | $89.80 | 2025 | Flexitouch Plus, Nimbl |
| Musculoskeletal Transplant Foundation INC. | $38.49 | 2024-2025 | |
| Mindray Ds USA, INC. | $25.32 | 2024 | Te X, Te7 Max |
| Acera Surgical, INC. | $15.31 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Y-Vu Van listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.